Three models were constructed: Model 1 (crude model), Model 2 (adjusted for age and sex), and Model 3 (fully adjusted for potential confounders including BMI, blood pressure, lipid profile, renal function, osteocalcin (OCN), vitamin D levels, HbA1c, statin use, antihypertensive medication use, and smoking status)
It focuses solely on tracking injections, removing unnecessary features
By Route of Administration: Oral Pills Poised to Disrupt Injectable Hegemony Injectable formulations generated 75.63% of revenue in 2025, yet oral candidates are forecast to grow at a brisk 34.87% CAGR, steadily enlarging their slice of the anti-obesity drugs market size
And he's vowed to go after the processed food industry and Big Pharma to make healthy eating front and center for Americans